Page last updated: 2024-09-05

bradykinin, sar-(d-phe(8))des-arg(9) and halothane

bradykinin, sar-(d-phe(8))des-arg(9) has been researched along with halothane in 1 studies

Compound Research Comparison

Studies
(bradykinin, sar-(d-phe(8))des-arg(9))
Trials
(bradykinin, sar-(d-phe(8))des-arg(9))
Recent Studies (post-2010)
(bradykinin, sar-(d-phe(8))des-arg(9))
Studies
(halothane)
Trials
(halothane)
Recent Studies (post-2010) (halothane)
180114,369884235

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Audet, R; Drapeau, G; Marceau, F; Rioux, F1

Other Studies

1 other study(ies) available for bradykinin, sar-(d-phe(8))des-arg(9) and halothane

ArticleYear
Cardiovascular effects of Sar-[D-Phe8]des-Arg9-bradykinin, a metabolically protected agonist of B1 receptor for kinins, in the anesthetized rabbit pretreated with a sublethal dose of bacterial lipopolysaccharide.
    The Journal of pharmacology and experimental therapeutics, 1997, Volume: 280, Issue:1

    Topics: Anesthesia; Animals; Bradykinin; Female; Halothane; Hemodynamics; Lipopolysaccharides; Male; Nitric Oxide; Rabbits; Receptor, Bradykinin B1; Receptors, Bradykinin

1997